Medicare announces plan to recoup billions from drug companies

Finally, industry advisor Curran said, this new guidance also offers a first highly anticipated look at the federal government's broader philosophical approach to wielding its pair of new powers."Everyone is going to be reading the tea leaves – are they being strict or less strict – and trying to draw conclusions from that."to reduce or waive rebates for companies whose drugs experience shortages or a supply chain disruption.

Medicare now turns its attention to finalizing and publishing similar guidance on price negotiation. It's an authority the industry is still surprised lawmakers managed to pass."​​We're having to wrestle with responding to guidance about something we never thought was going to happen," saidBryant said the forthcoming guidance, which targets some of the industry's top sellers, has the group's full attention.

Many experts believe that manufacturers will comb through those details looking not only for loopholes, but also for ammunition."Manufacturers are absolutely going to be looking to mount a legal challenge," said former Senate advisor Kaltenboeck. PhRMA said it expects pressure for legislative change to grow too.

Those legal stakes are one more reason people like former HHS official Richard Frank worry about the agency moving so fast through such technical work. The Affordable Care Act , the last health care law this consequential, was also written and implemented in a hurry. A few words"I do think the lessons learned from the ACA are fresh on people's minds," Richard Frank said.

Seshamani, who helped implement the ACA, said that's why the agency has"set up monthly technical calls with drug manufacturers [and] regular strategic policy meetings with patients groups, providers [and insurance] plans."

Nice!

Awwwww. Look at that look of optimism on that old man with dementia. Really gives you hope for the future. When he won’t be in “power.”

Nationalize the bastards if they want to FA they can FO

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Centene warns of hit to fast-growing Medicare Advantage business next yearCentene Corp on Tuesday said profit at its fast-growing Medicare Advantage (MA) business will take a beating in 2024 due to a sharp cut in its rating by a U.S. federal agency and likely lower-than-expected government payouts to health insurers.
Fonte: Reuters - 🏆 2. / 97 Consulte Mais informação »